414 related articles for article (PubMed ID: 29426286)
1. Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
Beiderlinden M; Werner P; Bahlmann A; Kemper J; Brezina T; Schäfer M; Görlinger K; Seidel H; Kienbaum P; Treschan TA
BMC Anesthesiol; 2018 Feb; 18(1):18. PubMed ID: 29426286
[TBL] [Abstract][Full Text] [Related]
2. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of Argatroban and Lepirudin: What is the Input of Laboratory Values in "Real Life"?
Seidel H; Kolde HJ
Clin Appl Thromb Hemost; 2018 Mar; 24(2):287-294. PubMed ID: 28320219
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time.
Engström M; Rundgren M; Schött U
Acta Anaesthesiol Scand; 2010 Jan; 54(1):86-91. PubMed ID: 19719819
[TBL] [Abstract][Full Text] [Related]
5. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
[TBL] [Abstract][Full Text] [Related]
6. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of anticoagulant effects of direct thrombin inhibitors.
Fenyvesi T; Jörg I; Harenberg J
Semin Thromb Hemost; 2002 Aug; 28(4):361-8. PubMed ID: 12244483
[TBL] [Abstract][Full Text] [Related]
8. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
[TBL] [Abstract][Full Text] [Related]
9. Lepirudin dose-dependently increases thrombelastography parameters at therapeutic plasma concentrations as measured with ROTEM® - a pilot study.
Feuring M; Wehling M; Schultz A
Int J Clin Pharmacol Ther; 2011 Oct; 49(10):626-8. PubMed ID: 21961488
[TBL] [Abstract][Full Text] [Related]
10. Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PiCT method.
Fenyvesi T; Jörg I; Harenberg J
Pathophysiol Haemost Thromb; 2002; 32(4):174-9. PubMed ID: 12759518
[TBL] [Abstract][Full Text] [Related]
11. Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation.
Warkentin TE; Greinacher A; Craven S; Dewar L; Sheppard JA; Ofosu FA
Thromb Haemost; 2005 Nov; 94(5):958-64. PubMed ID: 16363236
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods.
Ivandic B; Zorn M
Clin Appl Thromb Hemost; 2011 Oct; 17(5):549-55. PubMed ID: 20834029
[TBL] [Abstract][Full Text] [Related]
14. Alternative monitoring of argatroban using plasma-diluted thrombin time.
Wanat MA; Hart SR; Putney D; Liebl MG; Chandler W
Ann Pharmacother; 2013 Apr; 47(4):e18. PubMed ID: 23482736
[TBL] [Abstract][Full Text] [Related]
15. Argatroban and lepirudin requirements in a 6-year-old patient with heparin-induced thrombocytopenia.
John TE; Hallisey RK
Pharmacotherapy; 2005 Oct; 25(10):1383-8. PubMed ID: 16185183
[TBL] [Abstract][Full Text] [Related]
16. Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.
Guy S; Kitchen S; Maclean R; Van Veen JJ
Int J Lab Hematol; 2015 Dec; 37(6):834-43. PubMed ID: 26305560
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
Harenberg J; Jörg I; Fenyvesi T; Piazolo L
J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
[TBL] [Abstract][Full Text] [Related]
18. Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing.
Teruya J; Hensch L; Bruzdoski K; Adachi I; Hui SR; Kostousov V
Thromb Res; 2020 Feb; 186():54-57. PubMed ID: 31884000
[TBL] [Abstract][Full Text] [Related]
19. Collaborative study on monitoring methods to determine direct thrombin inhibitors lepirudin and argatroban.
Gray E; Harenberg J;
J Thromb Haemost; 2005 Sep; 3(9):2096-7. PubMed ID: 16102117
[No Abstract] [Full Text] [Related]
20. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
